LATEST ONCOPRESCRIBE UPDATES
Osimertinib Plus Chemotherapy Superior to Osimertinib Alone in Advanced EGFR Mutated Non Small Cell Lung Cancer
Germline Testing to Identify 11 Genes Linked to Aggressive Prostate Cancer
FDA Approves Pralsetinib for Non Small Cell Lung Cancer with RET gene fusions
FDA Approves Momelotinib for Patients with Myelofibrosis and Anemia
FDA Approves AKEEGA® for Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
Duration of Anticoagulation Therapy in Cancer Patients with Isolated Distal Deep Vein Thrombosis
Targeting ESR1 Mutations in Estrogen-Positive Advanced Breast Cancer
FDA Approves LONSURF® with Bevacizumab for Advanced Refractory Colorectal Cancer
